查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835372

术中放射线治疗市场（按应用、技术和最终用户划分）—2025-2032 年全球预测

Intraoperative Radiation Therapy Market by Application, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，术中放射线治疗市场将成长至 5.6367 亿美元，复合年增长率为 12.18%。

主要市场统计数据
基准年2024年 2.2459亿美元
预计2025年 2.5177亿美元
预测年份：2032年 5.6367亿美元
复合年增长率（%） 12.18%

术中放射线治疗将手术精准性与放射治疗的标靶化结合，减少了单次治疗中周围健康组织的放射暴露，并提供了一种整合多种治疗途径的治疗模式。过去十年，微型放射治疗系统的进步和临床通讯协定的完善，扩大了术中放射治疗（IORT）的适应症和应用范围。随着可携式平台和低能量设备的技术创新，IORT 正从高度专业化的三级医疗中心走向更广泛地应用于整个癌症治疗网络。

临床团队越来越多地考虑将眼内放射治疗 (IORT) 视为简化手术全期工作流程的一种手段，并可能减少某些患者群体接受长期外照射放射治疗的需求。外科医生、放射肿瘤学家、医学物理学家和护理人员之间的多学科合作支持了这一趋势。同时，设备製造商也注重人体工学、屏蔽效率和易于整合性，以降低手术复杂性并支援更广泛的临床应用。

监管机构和专业协会已完善了患者选择、放射安全和培训标准的指导，以确保实施的一致性和高品质。同时，医疗系统正在评估报销框架和医疗服务模式，以平衡前期投资与潜在的营运效率和以患者为中心的治疗结果。这些动态为临床专案负责人、设备製造商和付款方在评估术中放射治疗 (IORT) 在现代肿瘤治疗中的作用时做出策略决策奠定了基础。

临床、技术和护理服务的变革将推动整个医疗保健系统对术中放射治疗的更广泛考虑和操作整合

由于技术微型化、程序标准化以及医疗服务环境的变化，术中放射治疗领域正在发生重大变化。设备创新的重点是提高剂量适形性、降低屏蔽要求并实现移动性，从而降低其在门诊和社区医院环境中的应用门槛。因此，临床团队现在可以考虑在肿瘤切除时进行放射治疗，其精度更高，且物流限制更少，远远超出前几代设备。

同时，证据整合和真实世界结果报告使得患者选择更加清晰，并能够更细緻地决定哪些队列能从单一术中方法中获得最有意义的益处。这些临床改进与不断发展的培训框架相辅相成，这些框架强调跨学科协作、安全文化和可重复的手术流程。这些发展促使一些先前因营运复杂性而延后采用IORT的医疗中心重新评估其策略，并在跨职能部门的支持下试行IORT计画。

财务和政策环境也在发生变化，人们越来越重视基于价值的医疗模式和医疗整合。相关人员正在认识到术中放射治疗（IORT）的潜力，它可以透过压缩治疗环节来减轻患者的整体治疗负担，从而改善患者体验和依从性。总而言之，这些因素代表着局部控制策略如何融入手术环节的结构性转变，促使医疗保健提供者和製造商相应地调整其商业化、培训和服务模式。

评估近期关税和贸易动态如何改变采购决策、供应链弹性以及术中放射治疗系统的部署策略

影响医疗设备进口的关税政策可能会对供应链、筹资策略以及部署先进术中放射治疗系统的经济效益产生连锁反应。不断上涨的关税和贸易限制增加了进口设备和零件的到岸成本，迫使采购机构重新考虑采购时机、资金筹措安排和供应商选择。当采购团队预期进口成本会出现波动时，他们通常会选择拥有区域性製造地和多元化筹资策略的供应商，以降低这种风险。

此外，关税可能会影响设备製造商之间的竞争动态。拥有成熟国内製造能力或本地组装的公司可能更有能力维持稳定的价格和具有竞争力的前置作业时间，而依赖跨境零件流动的公司则可能自行吸收成本或将成本转嫁给买家。除了直接的价格效应外，如果对替换零件和耗材征收额外关税，关税还可能影响服务和维护的经济性，这可能会影响评估IORT投资的医疗保健系统的总拥有成本。

从临床营运的角度来看，采购延迟和设备成本上升可能会促使机构放慢专案推出时间表，并优先考虑分阶段实施、共用服务模式或分散资本投入的伙伴关係。此外，此类调整可能会改变术中放射治疗 (IORT) 服务的提供地点和方式，这可能会影响社区与学术中心的可及性。最终，贸易政策的变化凸显了弹性供应链规划、透明的成本模型和策略性供应商参与的重要性，以维持术中放射治疗倡议的实施动能。

細項分析揭示了临床应用、交付技术和医疗保健环境如何决定采用途径和程序设计选择

細項分析揭示了在应用、技术和最终用户维度上，采用率和临床价值的驱动因素存在细微差别。根据应用，该技术可用于脑肿瘤、乳癌和妇科癌症，每种癌症都有不同的手术工作流程、剂量需求以及多学科协作的需求，这些都影响着设备选择和方案设计。乳癌病例提供了单次分次放射治疗结合保乳治疗策略的机会，而妇科恶性肿瘤则可以在边缘控制至关重要的复杂骨盆切除术中利用术中推量。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合即时术中影像引导，优化放射治疗并最大程度减少正常组织暴露
  • 推出可携式术中放射系统，可在手术室内直接进行肿瘤床治疗
  • 低能量X射线源和电子近距离放射治疗的出现提高了术中放射治疗的精确度。
  • 越来越多的临床证据支持术中放射线治疗与免疫治疗相结合以改善患者预后
  • 不断扩大的报销政策和监管核准推动了全球市场对术中放射治疗的采用

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章术中放射线治疗市场（依应用）

  • 脑肿瘤
  • 乳癌
  • 妇科癌症

9. 术中放射线治疗市场（按技术）

  • 电子的
  • 低能量X射线
  • 可携式X射线

第 10 章。按最终用户分類的术中放射线治疗市场

  • 门诊手术中心
  • 癌症中心
  • 医院

第 11 章。按地区分類的术中放射线治疗市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 12 章。按组别分類的术中放射线治疗市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国术中放射线治疗市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Carl Zeiss Meditec AG
    • Ion Beam Applications SA
    • iCAD, Inc.
    • Sensus Healthcare, Inc.
    • IntraOp Medical, LLC
    • InfoMedics AG
    • Varian Medical Systems, Inc.
    • Accuray Incorporated
Product Code: MRR-43127F7279F0

The Intraoperative Radiation Therapy Market is projected to grow by USD 563.67 million at a CAGR of 12.18% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 224.59 million
Estimated Year [2025] USD 251.77 million
Forecast Year [2032] USD 563.67 million
CAGR (%) 12.18%

Intraoperative radiation therapy represents a convergence of surgical precision and targeted radiotherapeutic delivery, offering a single-encounter treatment paradigm that reduces radiation exposure to surrounding healthy tissue while consolidating care pathways. Over the past decade, advancements in compact radiation delivery systems and refinements in clinical protocols have expanded the range of indications and settings in which IORT can be considered. With ongoing innovation in portable platforms and low-energy devices, IORT is transitioning from highly specialized tertiary centers toward broader adoption across cancer care networks.

Clinical teams increasingly view IORT as a means to streamline perioperative workflows, potentially reducing the need for prolonged external beam radiotherapy in selected patient cohorts. This trend is supported by multidisciplinary collaboration among surgeons, radiation oncologists, medical physicists, and nursing staff, which is essential to integrate IORT into existing surgical and oncologic pathways. Concurrently, device makers have focused on ergonomics, shielding efficiency, and ease of integration to lower procedural complexity and support wider clinical uptake.

Regulatory authorities and professional societies have been refining guidance around patient selection, radiation safety, and training standards to ensure consistent, high-quality implementation. In parallel, health systems are evaluating reimbursement frameworks and care delivery models to balance upfront capital investment with potential operational efficiencies and patient-centric outcomes. Taken together, these dynamics set the stage for strategic decisions by clinical program leaders, device manufacturers, and payers seeking to evaluate the role of IORT within contemporary oncologic care.

Transformative clinical, technological, and care-delivery shifts driving broader consideration and operational integration of intraoperative radiation therapy across health systems

The landscape of intraoperative radiation therapy is undergoing transformative shifts driven by technological miniaturization, procedural standardization, and shifts in care delivery settings. Device innovation has focused on improving dose conformity, reducing shielding requirements, and enabling mobility, which collectively lower barriers to adoption in ambulatory and community hospital environments. As a result, clinical teams can contemplate delivering radiotherapy at the point of tumor resection with greater precision and fewer logistical constraints than in earlier generations of equipment.

Concurrently, evidence synthesis and real-world outcomes reporting have improved clarity around patient selection, enabling more nuanced decisions about which cohorts may derive the most meaningful benefit from a single-session intraoperative approach. These clinical refinements are complemented by evolving training frameworks that emphasize interdisciplinary coordination, safety culture, and reproducible procedural workflows. Because of these developments, institutions that once deferred adoption due to operational complexity are re-evaluating their strategies and piloting IORT programs with cross-functional support.

Financial and policy environments are also shifting, with greater attention to value-based care models and care consolidation. Stakeholders are assessing how IORT might reduce the overall treatment burden for patients by compressing therapy into the operative episode, potentially enhancing patient experience and adherence. Taken together, these forces represent a structural shift in how local control strategies can be integrated into the surgical episode, prompting both providers and manufacturers to adapt commercialization, training, and service models in response.

Assessing how recent tariff and trade dynamics can alter procurement decisions, supply chain resilience, and deployment strategies for intraoperative radiation therapy systems

Tariff policies affecting medical device imports can reverberate across supply chains, procurement strategies, and the economics of deploying advanced intraoperative radiation therapy systems. Increased duties or trade restrictions raise landed costs for imported equipment and components, which in turn can prompt purchasing organizations to re-evaluate acquisition timing, financing arrangements, and vendor selection. When procurement teams anticipate variable import costs, there is often a tendency to prefer suppliers with regional manufacturing footprints or diversified sourcing strategies to mitigate exposure.

Moreover, tariffs can influence the competitive dynamics among device manufacturers. Firms with established domestic production capabilities or localized assembly may be better positioned to maintain stable pricing and competitive lead times, while those reliant on cross-border component flows may absorb costs or pass them on to buyers. In addition to direct price effects, tariffs can affect service and maintenance economics if replacement parts and consumables become subject to additional duties, thereby influencing total cost of ownership considerations for health systems assessing IORT investments.

From a clinical operations perspective, procurement delays or higher equipment costs may slow program rollout timelines, prompting institutions to prioritize phased implementations, shared-service models, or partnerships that spread capital commitments. In turn, these adaptations can change where and how IORT services are offered, with potential implications for access in community settings versus academic centers. Ultimately, trade policy shifts underscore the importance of resilient supply chain planning, transparent cost modeling, and strategic vendor engagement to preserve implementation momentum for intraoperative radiation therapy initiatives.

Key segmentation insights revealing how clinical application, delivery technology, and care setting jointly determine adoption pathways and procedural design choices

Segmentation analysis reveals nuanced drivers of adoption and clinical value across application, technology, and end-user dimensions. Based on Application, the technology is applied across Brain Tumors, Breast Cancer, and Gynecological Cancer, each presenting distinct surgical workflows, dosimetric requirements, and multidisciplinary coordination needs that influence device selection and protocol design. Brain tumor procedures often demand high precision and specialized shielding considerations; breast cancer cases offer opportunities for single-fraction approaches tied to breast conservation strategies; gynecologic malignancies can leverage intraoperative boosts in complex pelvic resections where margin control is critical.

Based on Technology, offerings fall into categories including Electron, Low Energy X Ray, and Portable X Ray, with each modality presenting trade-offs in penetration depth, shielding infrastructure, and operating room integration. Electron-based systems deliver deeper tissue penetration suitable for certain tumor beds but often require more extensive shielding. Low energy X-ray platforms provide surface-weighted dose distributions favorable for select indications and may reduce shielding burdens. Portable X-ray devices prioritize mobility and streamlined workflows, enabling adoption in a wider range of surgical settings but with distinct clinical and dosimetric implications.

Based on End User, typical settings include Ambulatory Surgery Center, Cancer Center, and Hospital, each of which has different capital investment tolerance, staffing models, and patient throughput expectations that shape program feasibility. Ambulatory surgery centers may prioritize compact, low-footprint solutions that minimize capital and operational overhead, while cancer centers and hospitals can invest in more comprehensive infrastructure and multidisciplinary programs. Recognizing these segmentation dimensions helps stakeholders align technology choice, clinical protocols, and service delivery models to institutional capabilities and patient population needs.

Regional dynamics and adoption patterns that influence clinical program development, reimbursement alignment, and distribution strategies across global health markets

Regional perspectives on intraoperative radiation therapy highlight distinct drivers and barriers across major geographies. In the Americas, clinical networks and tertiary centers have been early adopters, supported by robust surgical oncology programs and a focus on consolidating perioperative care; however, variations in reimbursement practices and capital cycles influence where programs scale beyond major metropolitan centers. Transitional initiatives in community hospitals and selected ambulatory settings are increasingly visible as institutions seek to enhance local access to advanced oncologic therapies.

In Europe, Middle East & Africa, heterogeneous healthcare systems produce a mosaic of adoption patterns. High-resource centers in Western Europe have integrated IORT into specialized pathways, while some regions prioritize centralized delivery in referral institutions to concentrate expertise and manage resource utilization. Regulatory harmonization efforts and cross-border clinical collaborations play a role in knowledge dissemination and training, enabling centers of excellence to catalyze broader regional capability building.

In Asia-Pacific, rapid growth of surgical oncology services, investments in cancer infrastructure, and interest in portable and low-footprint devices are driving exploratory programs across both urban and peri-urban hospitals. Diverse payer models and evolving clinical guidelines shape adoption, and partnerships between local distributors and technology providers often determine the feasibility of expanding access. Across all regions, workforce training, radiation safety infrastructure, and alignment of clinical pathways remain central to sustainable program development.

Strategic competitive positioning and service-driven differentiators shaping supplier selection, clinical adoption, and long-term program sustainability in intraoperative radiation therapy

The competitive environment for intraoperative radiation therapy comprises established medical device firms, specialist radiation companies, and emerging entrants focused on novel delivery platforms and services. Players are differentiating through technological advancements such as compact generators, optimized applicators, and integrated imaging or navigation aids that enhance targeting and procedural efficiency. Strategic priorities include reducing shielding burdens, shortening setup times, and enabling seamless integration into the surgical workflow to lower operational friction and improve throughput.

Partnerships and service models are increasingly central to commercial strategies. Suppliers are offering bundled solutions that combine equipment with training programs, clinical support, and maintenance services to help healthcare providers achieve predictable implementation outcomes. Additionally, clinical evidence generation and post-market registries are becoming important competitive levers; firms that can demonstrate reproducible outcomes, procedural efficiency, and safety across diverse practice settings gain credibility with institutional purchasers and clinical champions.

Investment in after-sales support and regional service networks also affects adoption, particularly where uptime and rapid technical response are critical to surgical scheduling. As a result, companies that align product design with practical clinical workflows and offer robust education and service infrastructure are better positioned to influence program design decisions and long-term purchasing relationships.

Actionable recommendations for healthcare executives and clinical leaders to implement intraoperative radiation therapy programs with operational rigor and measurable outcomes

Leaders considering IORT adoption should prioritize actionable steps that align clinical value with operational feasibility. First, establish multidisciplinary governance that includes surgical, radiation oncology, medical physics, nursing, and administrative stakeholders to create reproducible protocols, define safety checklists, and manage training pathways. Early engagement across these groups accelerates consensus on patient selection criteria and procedural responsibilities, reducing implementation risk and ensuring consistent quality of care.

Second, evaluate procurement options that balance device capabilities with institutional workflow constraints. Consider total lifecycle implications including consumables, service contracts, and supply chain resilience. Where trade policy or sourcing risks exist, prioritize vendors with local assembly or diversified supply chains to preserve operational continuity. Pilot programs with phased scale-up can validate clinical and economic assumptions while providing necessary data to refine protocols.

Third, invest in outcome measurement and knowledge dissemination by establishing registries or participating in collaborative data initiatives. Transparent reporting on clinical outcomes, complication rates, and patient experience supports internal decision-making and external stakeholder confidence. Finally, align reimbursement and financial planning with clinical objectives by engaging payers early to articulate the potential patient-centric benefits and to explore case-based or bundled payment approaches that reflect the procedural consolidation enabled by intraoperative radiotherapy.

Transparent research methodology combining primary expert interviews, secondary clinical and regulatory analysis, and triangulated validation to ensure actionable and reliable insights

The research approach underpinning this analysis blended qualitative and quantitative techniques to produce a comprehensive view of intraoperative radiation therapy adoption, supply dynamics, and clinical practice patterns. Primary research included interviews with surgical oncologists, radiation oncologists, medical physicists, procurement leads, and device specialists to capture frontline operational insights and to identify barriers and enablers observed in real-world implementations. Secondary analysis comprised peer-reviewed clinical literature, regulatory documentation, health system reports, and publicly available technical specifications to corroborate clinical and technical assertions.

Triangulation methods were applied to reconcile differing perspectives and to ensure findings reflect both clinical evidence and operational realities. This included cross-referencing interview findings with device specifications and training frameworks, and validating regional adoption narratives against institutional case studies. In addition, scenario analysis was used to explore how supply chain disruptions, policy changes, or technological shifts could influence procurement and deployment choices, with an emphasis on practical implications rather than numerical forecasting.

Finally, quality controls included expert review of draft findings by clinicians and health system administrators to ensure accuracy, relevance, and applicability. The resulting synthesis emphasizes actionable insights, readiness considerations, and strategic options designed to support decision-making for clinical program leaders and commercial stakeholders.

Concluding synthesis on how technological progress and operational readiness together determine the sustainable integration of intraoperative radiation therapy within oncologic care pathways

Intraoperative radiation therapy stands at an inflection point where technological maturity, clinical evidence, and service model innovation converge to offer new pathways for perioperative oncologic care. Devices that reduce operational complexity and shielding requirements, coupled with standardized training and multidisciplinary governance, create realistic pathways for expanded adoption beyond early adopter institutions. This evolution promises improved integration of local control strategies into single-encounter surgical care while also demanding careful attention to implementation logistics and long-term service commitments.

As care delivery and procurement landscapes evolve, stakeholders should approach IORT adoption with a balanced view that weighs clinical potential against operational, regulatory, and supply chain realities. Effective programs will be those that plan comprehensively: defining clinical indications clearly, investing in multidisciplinary training, ensuring device selection aligns with institutional workflows, and establishing mechanisms for outcome measurement and continual improvement. When these elements are combined, IORT can become a reliable component of contemporary oncologic practice, improving the patient experience while fitting into broader strategic objectives for surgical and radiation oncology services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of real-time intraoperative imaging guidance to optimize radiation targeting and minimize normal tissue exposure
  • 5.2. Adoption of portable intraoperative radiation systems enabling direct tumor bed treatment within operating rooms
  • 5.3. Emergence of low-energy x-ray sources and electronic brachytherapy for precision intraoperative radiation delivery
  • 5.4. Rising clinical evidence supporting combined intraoperative radiation therapy and immunotherapy to improve patient outcomes
  • 5.5. Expanded reimbursement policies and regulatory approvals driving adoption of intraoperative radiation across global markets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative Radiation Therapy Market, by Application

  • 8.1. Brain Tumors
  • 8.2. Breast Cancer
  • 8.3. Gynecological Cancer

9. Intraoperative Radiation Therapy Market, by Technology

  • 9.1. Electron
  • 9.2. Low Energy X Ray
  • 9.3. Portable X Ray

10. Intraoperative Radiation Therapy Market, by End User

  • 10.1. Ambulatory Surgery Center
  • 10.2. Cancer Center
  • 10.3. Hospital

11. Intraoperative Radiation Therapy Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Intraoperative Radiation Therapy Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Intraoperative Radiation Therapy Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Carl Zeiss Meditec AG
    • 14.3.2. Ion Beam Applications SA
    • 14.3.3. iCAD, Inc.
    • 14.3.4. Sensus Healthcare, Inc.
    • 14.3.5. IntraOp Medical, LLC
    • 14.3.6. InfoMedics AG
    • 14.3.7. Varian Medical Systems, Inc.
    • 14.3.8. Accuray Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. INTRAOPERATIVE RADIATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE RADIATION THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY ELECTRON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY LOW ENERGY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY PORTABLE X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY CANCER CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 69. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 71. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 73. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 78. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 82. NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. LATIN AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 103. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 104. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 105. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. EUROPE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 112. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. MIDDLE EAST INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. AFRICA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 139. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. ASEAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GCC INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPEAN UNION INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. BRICS INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. G7 INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. NATO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. CANADA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. CANADA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. CANADA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. BRAZIL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. BRAZIL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. BRAZIL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. UNITED KINGDOM INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. UNITED KINGDOM INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. GERMANY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. GERMANY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. GERMANY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. GERMANY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. GERMANY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. FRANCE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. FRANCE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. FRANCE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. FRANCE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. FRANCE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. RUSSIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. RUSSIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. RUSSIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. RUSSIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. RUSSIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. RUSSIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. ITALY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. ITALY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. ITALY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. ITALY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. ITALY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ITALY INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. SPAIN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. SPAIN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. SPAIN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. SPAIN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. CHINA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. INDIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. INDIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. INDIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. INDIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. INDIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. INDIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. JAPAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. JAPAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. JAPAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. JAPAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. JAPAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. JAPAN INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AUSTRALIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. AUSTRALIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. AUSTRALIA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. SOUTH KOREA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. SOUTH KOREA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. SOUTH KOREA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 271. SOUTH KOREA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. SOUTH KOREA INTRAOPERATIVE RADIATION THERAPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 274. INTRAOPERATIVE RADIATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2024